Medical Device News Magazine

Filterlex Medical, Selected to Receive €7M from the European Innovation Council

Equity investment to support advancement of its breakthrough full-body embolic protection device to reduce the risk of stroke and other complications during left-heart procedures.

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Summation

  • Following a rigorous screening process under Horizon 2020, Filterlex’s innovative technology was selected as one of only 99 winning companies out of over 1000, from 21 countries to receive EIC funding from a total of €627 Million available.

Filterlex Medical, a cardiovascular medical device startup, announced today that it has been selected to receive €7 Million equity investment from the European Innovation Council Accelerator (EIC). The EIC equity investment will be a part of Filterlex’s next round of financing.

This combined funding will go towards clinical program expansion, regulatory approvals, and commercialization of the CAPTIS® full-body embolic protection system to help transform left-heart procedures.

Following a rigorous screening process under Horizon 2020, Filterlex’s innovative technology was selected as one of only 99 winning companies out of over 1000, from 21 countries to receive EIC funding from a total of €627 Million available. Entrants must meet EIC criteria for excellence, impact, and risk level, and by the time they reach the final selection stage are considered to be world-class high-impact innovations. Filterlex was also one of only 19% of companies run by a female CEO.

The EIC investment commitment follows Filterlex’s recent rapid closing of a US $6 Million series A1 investment round in November 2021. The company is also a past recipient of a €2.1 Million EU Horizon 2019 grant, which was pivotal in financing the CAPTIS first-in-human study.

Founder and CEO, Sigal Eli, said: “We are delighted to be selected to receive EIC funding for the second time. This EU validation will help us to further advance our technology and turn our vision into a reality to make the CAPTIS a best-in-class device for reducing the risk of stroke and other complications during catheter-based structural heart procedures such as TAVR.”

Filterlex is currently enrolling patients in its successfully ongoing CAPTIS first-in-human study in Israel.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

HeartFlow Introduces Next Generation Interactive Plaque Analysis Platform to Assess Patient Risk in Suspected Coronary Artery Disease

The HeartFlow Plaque Analysis uses proprietary algorithms to analyze coronary CT angiogram (CCTA) scans, creating a personalized 3D model that quantifies and characterizes plaque volume in the coronary arteries, aiding risk assessment of coronary artery disease. The technology was introduced at the Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting in Washington, D.C.

Ultrahuman Announces its App Store ‘PowerPlugs’ with the World’s First AFib Detection Technology on a Smart Ring

Recognizing each individual’s health journey is unique, PowerPlugs enable people to choose and focus on the aspects of their health that matter most. It’s designed for highly personalized health insights, ensuring that every individual can personalize their health tracking to their unique needs and goals.

VisionAir Solutions Celebrates Milestone and New Collaboration

This achievement marks VisionAir Solutions commitment to bringing technological innovation to pulmonary medicine. Since its acquisition by Theken Companies last year, VAS has over doubled its growth and continues to demonstrate industry adoption and the advantages of personalized healthcare.